Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases.

Journal: Metabolic brain disease

Volume: 36

Issue: 6

Year of Publication: 2022

Affiliated Institutions:  Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. sjvr@sun.ac.za. Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Department of Internal Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Academic Hospital, Cape Town, South Africa. Division of Chemical Pathology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, National Health Laboratory Service (NHLS), Cape Town, South Africa. Central Analytical Facility (CAF), DNA Sequencing Unit, Stellenbosch University, Stellenbosch, South Africa. Department of Medical Imaging and Therapeutic Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Cape Town, South Africa. Department of Psychiatry and Mental Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. Genetic Care Centre, Tygerberg Academic Hospital, Cape Town, South Africa. Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Cape Town, South Africa. Department of Pediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Abstract summary 

In Part I of this Review we evaluated the scientific evidence for a Metabolic Model of multiple sclerosis (MS). Part II outlines the implementation of an adaptive pathology-supported genetic testing (PSGT) algorithm aimed at preventing/reversing disability in two illustrative MS cases, starting with a questionnaire-based risk assessment, including family history and lifestyle factors. Measurement of iron, vitamin B12, vitamin D, cholesterol and homocysteine levels identified biochemical deficits in both cases. Case 1, after following the PSGT program for 15 years, had an expanded disability status scale (EDSS) of 2.0 (no neurological sequelae) together with preserved brain volume on magnetic resonance imaging (MRI). A novel form of iron deficiency was identified in Case 1, as biochemical testing at each hospital submission due to MS symptoms showed low serum iron, ferritin and transferrin saturation, while hematological status and erythrocyte sedimentation rate measurement of systemic inflammation remained normal. Case 2 was unable to walk unaided until her EDSS improved from 6.5 to 4.0 over 12 months after implementation of the PSGT program, with amelioration of her suboptimal biochemical markers and changes to her diet and lifestyle, allowing her to regain independence. Genotype-phenotype correlation using a pathway panel of functional single nucleotide variants (SNVs) to facilitate clinical interpretation of whole exome sequencing (WES), elucidated the underlying metabolic pathways related to the biochemical deficits. A cure for MS will remain an elusive goal if separated from nutritional support required for production and maintenance of myelin, which can only be achieved by a lifelong investment in wellness.

Authors & Co-authors:  van Rensburg Susan J SJ Hattingh Coenraad C Johannes Clint C Moremi Kelebogile E KE Peeters Armand V AV van Heerden Carel J CJ Erasmus Rajiv T RT Zemlin Annalise E AE Kemp Merlisa C MC Jaftha Mariaan M Khine Aye Aye AA Potocnik Felix C V FCV Whati Lindiwe L Engel-Hills Penelope P van Toorn Ronald R Kotze Maritha J MJ

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Abbaspour N, Hurrell R, Kelishadi R (2014) Review on iron and its importance for human health. J Res Med Sci 19:164–174
Authors :  16
Identifiers
Doi : 10.1007/s11011-021-00712-9
SSN : 1573-7365
Study Population
Male,Female
Mesh Terms
Genetic Testing
Other Terms
Biochemical markers;Disability prevention;Multiple sclerosis;Nutritional reserve;Pathology-supported genetic testing (PSGT);Whole exome sequencing (WES)
Study Design
Case Study,Cross Sectional Study
Study Approach
Systemic Review
Country of Study
Publication Country
United States